Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.

@article{Lim2010ResidualCS,
  title={Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.},
  author={Myong Cheol Lim and Yong Jung Song and S. U. Seo and Chong-Woo Yoo and Sokbom Kang and Sang-yoon Park},
  journal={Onkologie},
  year={2010},
  volume={33 6},
  pages={324-30}
}
The objective of this review is to discuss the common surgical strategy of cytoreductive surgery after neoadjuvant chemotherapy, with an emphasis on incorporating extensive cytoreductive surgery to remove traces of regressed tumor. A review of the literature regarding cytoreductive surgery after neoadjuvant chemotherapy and cancer stem cells is given together with the authors' own experience and comments. Most ovarian cancer cells consist of transformed cells that regress after neoadjuvant… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

Springer Singapore • 2018
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…